Survival outcomes in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy: a meta-analysis

The survival outcomes in HER2-low versus HER2-zero breast cancer (BC) after neoadjuvant chemotherapy (NACT) remain unclear. The meta-analysis was conducted to summarize current evidence about the survival outc...

Source: World Journal of Surgical Oncology - April 20, 2024 Category: Cancer & Oncology Authors: Lin-Yu Xia, Xu-Chen Cao and Yue Yu Tags: Research Source Type: research